Paolo Lopedote

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Circulating Tumor Cells

Multiple Myeloma

Prognostic Factors

Ejection Fraction

Top Venues

Cancer management and research

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Lopedote, Benjamin Evans, Alfredo Marchetti, Tianzeng Chen, Maria Moscvin, Samuel Boullt, Niccolo' Bolli, Giada Bianchi
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis. Blood advances 8 (13) (2024)
Paolo Lopedote, Benjamin Evans, Alfredo Marchetti, Tianzeng Chen, Maria Moscvin, Samuel Boullt, Niccolo' Bolli, Giada Bianchi
Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis. Blood advances (2024)
Paolo Lopedote, Benjamin Evans, Alfredo Marchetti, Tianzeng Chen, Maria Moscvin, Samuel Boullt, Niccolo' Bolli, Giada Bianchi
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis. Blood advances 8 (13) (2024)
Paolo Lopedote, Benjamin Evans, Alfredo Marchetti, Tianzeng Chen, Maria Moscvin, Samuel Boullt, Niccolo' Bolli, Giada Bianchi
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis. Blood advances 8 (13) (2024)
Paolo Lopedote, Mazyar Shadman
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab. Cancer management and research 15 (2023)
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, Ilenia Iamundo De Cumis, Alessandro Pulsoni, Paolo Strati
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond. Cancers 15 (10) (2023)
Paolo Lopedote, Mazyar Shadman
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab. Cancer management and research 15 (2023)
Salvatore Perrone, Paolo Lopedote, Mario Levis, Alice Di Rocco, Stephen Douglas Smith
Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert review of hematology 15 (3) (2022)